Company profile · Biotech & medical
SCI Pharmtech
旭富製藥科技股份有限公司 · 4119
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
SCI Pharmtech engages in the research, development, production, and marketing of active pharmaceutical ingredients, advanced intermediates, and special and precision chemicals.[1]
The company sells its products to major pharmaceutical companies in Europe, the Americas, and Japan.[2]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$131m | +30.4% | -19.8% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$22m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | SCI Pharmtech, Inc. |
|---|---|
| Chinese name | 旭富製藥科技股份有限公司 |
| Stock code | 4119 (TWSE) |
| Industry | Biotech & medical |
| Founded | 18 Sep 1987 |
| Listed | 07 Jan 2004 |
| Paid-in capital | NT$1.2bn |
| Chairman | 翁維駿 |
| President | 周文智 |
| Headquarters | No.61, Ln. 309, Haihu N. Rd., Luzhu Dist., Taoyuan City ,Taiwan 33856 |
| Website | https://www.sci-pharmtech.com.tw |
| Official business description | 原料藥,原料藥中間體,特殊及精密化學品之加工,製造及銷售 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- MOPS 公司基本資料 旭富製藥科技股份有限公司 · mops · retrieved 04 Nov 2026
- 旭富製藥科技股份有限公司 · website · retrieved 04 Nov 2026
Using it at work? Join the team-plan waiting list